Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 2
2004 3
2005 2
2006 3
2007 6
2008 5
2009 5
2010 4
2012 2
2013 4
2014 10
2015 5
2016 2
2018 3
2019 2
2020 7
2021 7
2022 6
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Primary refractory plasmablastic lymphoma: A precision oncology approach.
Witte HM, Fähnrich A, Künstner A, Riedl J, Fliedner SMJ, Reimer N, Hertel N, von Bubnoff N, Bernard V, Merz H, Busch H, Feller A, Gebauer N. Witte HM, et al. Among authors: merz h. Front Oncol. 2023 Feb 27;13:1129405. doi: 10.3389/fonc.2023.1129405. eCollection 2023. Front Oncol. 2023. PMID: 36923431 Free PMC article.
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing.
Künstner A, Witte HM, Riedl J, Bernard V, Stölting S, Merz H, Olschewski V, Peter W, Ketzer J, Busch Y, Trojok P, Bubnoff NV, Busch H, Feller AC, Gebauer N. Künstner A, et al. Among authors: merz h. Haematologica. 2022 Aug 1;107(8):1850-1863. doi: 10.3324/haematol.2021.279631. Haematologica. 2022. PMID: 34788985 Free PMC article.
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6).
Witte HM, Riedl J, Künstner A, Fähnrich A, Ketzer J, Fliedner SMJ, Reimer N, Bernard V, von Bubnoff N, Merz H, Busch H, Feller A, Gebauer N. Witte HM, et al. Among authors: merz h. Target Oncol. 2023 Sep;18(5):749-765. doi: 10.1007/s11523-023-00983-5. Epub 2023 Jul 24. Target Oncol. 2023. PMID: 37488307 Free PMC article.
Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm.
Künstner A, Schwarting J, Witte HM, Bernard V, Stölting S, Kusch K, Nagarathinam K, von Bubnoff N, Murga Penas EM, Merz H, Busch H, Feller AC, Gebauer N. Künstner A, et al. Among authors: merz h. Blood Cancer J. 2022 Jul 4;12(7):101. doi: 10.1038/s41408-022-00699-1. Blood Cancer J. 2022. PMID: 35788129 Free PMC article. No abstract available.
75 results